secwatch.observer — SEC 8-K summary
======================================

Issuer:     CYPHERPUNK TECHNOLOGIES INC. (CYPH)
CIK:        0001509745
Form:       8-K
Filed at:   2025-10-06T23:59:59+00:00
Accession:  0001104659-25-096966
Event type: other_material
Sentiment:  neutral
Materiality: 0.85
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Leap Therapeutics raises $58.9M in PIPE led by Winklevoss Capital, adopts digital asset treasury strategy
--------------------------------------------------------------------------------

- $58,888,888 in cash commitments for PIPE offering at $0.61439 per unit, led by Winklevoss Capital.
- Issues 95.8M shares/pre-funded warrants and 71.9M warrants exercisable at $0.5335 per share.
- Closing expected October 8, 2025; Winklevoss Capital to nominate two board members, one as chair.
- Proceeds to fund digital asset treasury strategy and continued development of FL-501 and sirexatamab.
- Company reaffirms pursuit of existing biotech pipeline alongside new digital asset strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1509745/000110465925096966/0001104659-25-096966-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1509745/000110465925096966/tm2528058d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-096966

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer